JPM Week 2027 · San Francisco
Meet us at JPM
One nitric oxide platform. Multiple potential indications.
Let’s connect
Explore what we can build together.
NOxy is advancing a topical nitric oxide platform, led by NOX1416, with a primary focus on deep tissue pressure injuries and expansion into inflammatory dermatology, including vulvar lichen sclerosus.
We welcome conversations with investors and strategic partners who see the opportunity to advance multiple indications through a shared platform.
